Turing reneges on drug price cut, rival’s version sells well

November 26, 2015 2:21 AM

30 0

Turing reneges on drug price cut, rival’s version sells well

TRENTON, N.J. — After weeks of criticism from patients, doctors and other drugmakers for hiking a life-saving medicine to more than 50 times its former price, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

Instead, the small biotech company is reducing what it charges hospitals, by up to 50 percent, for its parasitic infection treatment Daraprim. Most patients’ co-payments will be capped at $10 or less a month. But insurers will be stuck with the bulk of the $750 tab. That drives up future treatment a...

Also read: Dolphins player Leon Orr cut after arrest on drug charges

Read more

To category page

Loading...